<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83090">
  <stage>Registered</stage>
  <submitdate>28/08/2008</submitdate>
  <approvaldate>15/10/2008</approvaldate>
  <actrnumber>ACTRN12608000529347</actrnumber>
  <trial_identification>
    <studytitle>Prospective Screening for Osteoporosis; Australian Primary Care Evaluation of Clinical Tests</studytitle>
    <scientifictitle>The prevalence of osteoporosis and vertebral fractures in a primary care setting assessed by clinical and radiology tests</scientifictitle>
    <utrn />
    <trialacronym>PROSPECT</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Osteoporosis</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoporosis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Cross sectional survey to identify the prevalence of osteoporosis, the prevelance of vertebral fractures in the Australian primary care setting. General Practitioners (GPs) completed a case report form for consecutive patients who were 70 years of age and over and did not have a previous diagnosis of osteoporosis. The case report form included patient demographics, medical history, medications, clinical tests etc. and took approximately 10 minutes to complete. GPs refer patients for a Dual-energy X-ray Absorptiometry (DEXA) and verterbral X-ray scan at local I-med radiology centres, participating in the study. Second x-ray readings are performed by a single radiologist. The data is collected prospectively over a period of 6 months with GPs participating in the study for the same length of time.</interventions>
    <comparator>N/A - observational study</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
    <interventioncode>Early detection / Screening</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The prevalance of osteoporosis and verterbral fracture in a primary care setting, will be determined using the reports from radiology tests.</outcome>
      <timepoint>14 November 2008, study close: all patient data submitted for analysis</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Examine predictors of osteoporosis and fracture using the survey data provided and a logistical regression model.</outcome>
      <timepoint>End of December 2008: Database lock</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Women aged 70 years and over, who have not had a previous diagnosis of osteoporosis.</inclusivecriteria>
    <inclusiveminage>70</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Inability to read or give informed consent in English; previous diagnosis of osteoporosis; a history of a DEXA scan in the last 2 years; significant chronic disease that in itself is an indication for the patient to have a DEXA scan, a history of more than 6 months use of raloxifene, bisphosphonate, strontium ranelate, 1,25 vitamin D or parathyroid hormone (PTH) analogue; use of systemic hormone replacement therapy (HRT) within the last 2 years.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>5/08/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>4000</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Prof Leon Piterman AM</primarysponsorname>
    <primarysponsoraddress>Department of General Practice
Monash University
Building 1, 270 Ferntree Gully Road
Notting Hill VIC 3168</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Servier Laboratories</fundingname>
      <fundingaddress>8 Cato Street
Hawthorn VIC 3122</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will assess how a sample group of approximately 4000 elderly patients are being screened and daignosed for osteoporosis.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Standing Committee on Ethics in Research involving Humans (SCERH)</ethicname>
      <ethicaddress>Human Ethics Office
First Floor, Building 3E, Room 111
Monash University VIC 3800</ethicaddress>
      <ethicapprovaldate>14/03/2008</ethicapprovaldate>
      <hrec>CF08/0155-2008000030</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Andrew Weekes</name>
      <address>8 Cato Street
Hawthorn VIC 3122</address>
      <phone>1800 654 311</phone>
      <fax>03 9822 4190</fax>
      <email>andrew.weekes@au.netgrs.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Andrew Weekes</name>
      <address>8 Cato Street
Hawrthorn VIC 3122</address>
      <phone>1800 654 311</phone>
      <fax>03 9822 4190</fax>
      <email>andrew.weekes@au.netgrs.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Alfred Lanzafame</name>
      <address>8 Cato Street
Hawthorn VIC 3122</address>
      <phone>1800 654 311</phone>
      <fax>03 9822 4190</fax>
      <email>alfred.lanzafame@au.netgrs.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>